About Us

About Us

The world's only dna aptamer material patent-based
global bio company leader

Mission & Vision

Based On The World’s first DNA Aptamer Patent, Becoming A Global Therapeutics and Healthcare Market Leader

  • DNA R&D Innovator

    Started business with R&D for the innovative DNA-based AD/PD medicines, and expand the business to healthcare and cosmeceutical markets

  • Global ingredient IPs

    World’s first perfect antioxidants DNA Aptamer, Aptamin® patents rights owner (30+)

  • Game Changer

    Go to global, and suggest new industrial standards with DNA Aptamer

Business Scope

Company History

  • 2020 ~ 2018
  • 2017 ~ 2014
  • 2020
    Aptamin®C GRAS Notification (FDA, US)
    Aptamin®C additional patent registration (US, Korea)
  • 2019
    Developed Aptamin®C ingredient for skincare
    Launched Aptamin®C finished cosmetic goods
    Posted an study results of Aptamin®C skincare on Journal of Cosmetic Dermatology
    Venture Business Certification
    TIDES, Poster Presentation
    AMWC, Poster Presentation
    InCosmetics Global, CosmeTech
    Started co-research with Kyunghee University, Chungang University, Sookmyung Women’s University
  • 2018
    Developed Aptamin®H, K, G
    Publish Aptamin®C, Aptamers
    Aptamin®C Korea Cosmetic Association Registration
    IFSCC, Poster Presentation
    IPO, Selection of an organizing company(KB securities)
  • 2017
    Aptamin®C ICID register
    Co-developed Aptamin® with Hanyang Universigy
  • 2016
    Developed Aptamin®C
    Gold prizes awarded in <Huzel Open Innovation>
  • 2015
    Developed microneedle patch type of early diagnosis system
  • 2014
    Developed contact-lens type of early diagnosis system
    Founded

Business Roadmap

Entering the global healthcare market with the start of commercializing the first DNA Aptamer in worldwide

IP(Intellectual Property)

Intellectual Property Status

2 1 7 2 7 14 8 7 PCT2 Processing
(41)
Registered
(7)
Area Applied PCT Registered Total
Aptamin® 24 2 7 33
Therapeutics 12 12
Early Diagnosis 5 5
Other
Total 41 2 7 50
  • 5
  • 7
  • 4

Executives

  • Key members
  • Advisory
  • CEO

    Jung-Wook Shim

    Aptamin Lab Co, CEO
    ATD CAPS Co, V. President
    Naturerepublic Co, a V. President
    The Face Shop CO, executive director
    Economics at Seoul National University

  • Executive Vice President

    Kang-Joon Cho

    Aptamin Lab Co, V. President
    KTB Investment & Securities Co, director
    LIG Investment & Securities Co, director
    Economics at Seoul National University

  • R&D Advisor

    Yoonsung Kim, M.D., Ph.D.

    Rutgers University Medical School
    Weill Cornell Medicine
    Ph.D. in Medical School, Cornell Univ.

  • R&D Advisor

    Jae-Seung Kang, Ph.D.

    SNU therapeutics
    Anatomy and Cell Biology
    Ph.D. Seoul National University College of therapeutics

  • R&D Advisor

    Yeongjeong Kim, Ph.D.

    Dept. of Nursing Science,
    Kyunghee University
    Post-doc. Fellowship, Weill Medical School, Cornell Univ.
    Ph.D, Kyunghee University

  • R&D Advisor

    Jin-ho Lee

    Pentaheal Clinic, director
    Yonsei University College of therapeutics

Partners & Customers

  • partner01.jpg
  • partner02.jpg
  • partner03.jpg
  • partner04.jpg
  • partner05.jpg
  • partner06.jpg
  • partner07.jpg
  • partner08.jpg
  • partner09.jpg
  • partner10.jpg
  • partner11.jpg
  • partner12.jpg
  • partner13.jpg
  • partner14.jpg
  • partner15.jpg
  • partner16.jpg
  • partner17.jpg
  • partner18.jpg
  • partner20.jpg
  • partner21.jpg
  • partner23.jpg
  • partner24.jpg
  • partner25.jpg
  • partner26.jpg
  • partner27.jpg
  • partner28.jpg